Business idea · Agency
Longevity Drug Development for Aging
Longevity Drug Development for Aging: This startup focuses on researching and developing pharmaceutical treatments aimed at extending healthy lifespan through targeting aging processes at the cellular level. It was pitched on My First Million, hosted by Sam Parr and Shaan Puri, in the episode "How Silicon Valley’s Most Prolific Investor Picks Unicorns | Elad Gil Interview" (aired October 8, 2024).
At a glance
| Podcast | My First Million |
|---|---|
| Hosted by | Sam Parr and Shaan Puri |
| Episode | How Silicon Valley’s Most Prolific Investor Picks Unicorns | Elad Gil Interview |
| Aired | October 8, 2024 |
| Category | Agency |
| Real companies on the episode | Ilad Gil's Investment Strategies |
The problem it solves
The aging population faces numerous health challenges, with current treatments focusing mainly on age-related diseases rather than the aging process itself. There is a significant lack of investment and research in aging as a field, leading to underdeveloped therapies.
How it makes money
Pharmaceutical licensing and partnership model with potential for direct sales to healthcare providers.
Skills you need
Background in biomedical research and pharmacology Experience in clinical trials and regulatory compliance Knowledge of the pharmaceutical industry and drug commercialization
The market, and why this works now
CRISPR technology enables precise targeting of genes associated with aging, making it viable to develop therapies that address the aging process directly. A potential first revenue move involves partnering with specialized online forums such as the Longevity subreddit, where discussions about anti-aging research can attract early interest and funding. Founders should consider the significant capital required for clinical trials and navigating regulatory approvals, which can extend the timeline to profitability.
Our analysis, written after the episode. Not a quote from the show.
Real companies discussed on this episode
- Ilad Gil's Investment Strategies
Ilad Gil is a renowned angel investor, having invested in over 40 unicorns, including Airbnb and Airtable, primarily focusing on early-stage ventures. He emphasizes a market-first approach, assessing the viability of the market and product-market fit before the founders themselves.
Where this idea came from
Podcast: My First Million, hosted by Sam Parr and Shaan Puri
Episode: How Silicon Valley’s Most Prolific Investor Picks Unicorns | Elad Gil Interview
Aired:
Summarized from the episode transcript. The show does not say which speaker raised each idea, so we credit the show, not a person.